Table 3. Maintenance mediations used for asthma control in the past four weeks according to the patients or their parents/guardians.a.
| Variables | Groups | ||
|---|---|---|---|
| CA | PCA | UA | |
| (n = 36) | (n = 226) | (n = 137) | |
| None | 20 (55.6) | 81 (35.8) | 20 (14.6) |
| Short-acting bronchodilator | 12 (33.3) | 81 (35.8) | 73 (53.3) |
| Tiotropium | 0 (0.0) | 1 (0.4) | 0 (0.0) |
| IC alone | 1 (2.8) | 11 (4.9) | 12 (8.8) |
| LAB + IC | 0 (0.0) | 18 (8.0) | 21 (15.3) |
| LAB alone | 2 (5.6) | 8 (3.5) | 0 (0.0) |
| Aminophylline | 0 (0.0) | 6 (2.7) | 4 (2.9) |
| Unknown | 0 (0.0) | 11 (4.9) | 3 (2.2) |
| Others | 1 (2.8) | 9 (4.0) | 4 (2.9) |
CA: controlled asthma; PCA: partially controlled asthma; UA: uncontrolled asthma; IC: inhaled corticosteroid; and LAB: long-acting bronchodilator. aValues expressed as n (%)